4 hrs ago | The Age
PUBLIC health experts have hit back against claims Australia's childhood obesity plague is a myth, with figures that they say show the problem is actually understated.
12 hrs ago | MediLexicon
European Medicines Agency Update On Safety Of Insulin Glargine
The European Medicines Agency is looking into four recently published registry studies investigating a possible relationship between insulin analogues, in particular insulin glargine, and the risk of cancer.
Complementary and alternative treatments for arthritis
Arthritis is a disease that causes pain, swelling, stiffness, tenderness and redness in your joints.
Other countries and cultures have a lot to teach us about eating right. There is a universal wisdom to healthy eating.
'Jumping gene' diminishes the effect of a new type 2 diabetes risk gene
Research led by the German Institute of Human Nutrition has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes.
Treatment That Significantly Slows Progression Of Eye Damage In...
Main Category: Eye Health / Blindness Also Included In: Diabetes Article Date: 03 Jul 2009 - 0:00 PDT University of Minnesota Medical School researcher Michael Mauer, M.D., has found a treatment that significantly slows the progression of eye injury in people with type 1 diabetes , a common complication caused by this disease.
Exercise helps patients with non-alcoholic fatty liver disease
Counseling patients with non-alcoholic fatty liver disease on how to increase physical activity leads to health benefits that are independent of changes in weight.
DANISH pharmaceuticals group Novo Nordisk's diabetes drug Victoza, a key driver for future sales, has won European Commission approval for marketing across the European Union, the company said yesterday.
Kids With Type 1 Diabetes Often Overweight
Children with type 1 diabetes are more likely to be overweight than those without the disease, increasing their risk of serious health complications, researchers say.
Blood Pressure Drugs Slow Eye Problems In Diabetes
Two Merck blood pressure drugs given to diabetics to prevent worsening kidney problems do not work in that way but may prevent diabetes-related eye problems, researchers reported on Wednesday.
Study examines dietary influences of liver disease
Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk.
If your doctor has said you have prediabetes, you may not feel too concerned. But don't take it lightly.
Natural Compound Stops Diabetic Retinopathy
Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States.
2009 Dr. Paul Janssen Award For Biomedical Research Won By Axel Ullrich
Johnson & Johnson has announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin , is the winner of the 2009 Dr.
Lap-Band Weight-Loss Surgery Can Reverse Metabolic Syndrome in Obese Teens
A new study of obese adolescents has shown that laparoscopic gastric banding surgery -- the "Lap-Band" procedure -- not only helps them achieve significant weight loss but can also improve and even reverse metabolic syndrome, reducing their risk for cardiovascular disease and diabetes.
Drugs May Not Slow Kidney Damage in Diabetes
Results from a new trial have dashed hopes that early use of two blood pressure drugs could slow the loss of kidney function caused by type 1 diabetes.
How diabetes affects your feet
They carry you everywhere. You dress them with snug slippers, comfy sneakers and strappy sandals.
Joint Replacement Patients That Have Diabetes Greatly Benefit From Controlled Glucose
A Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions.
FDA reviewing safety of Sanofi's Lantus insulin
The Food and Drug Administration said Wednesday it is reviewing data on the safety of Lantus, a synthetic insulin made by Sanofi-Aventis SA.
Two Thirds Of People With Diabetes Not Receiving Vital Health Checks, UK
The latest National Diabetes Audit has revealed that 60 per cent of people with diabetes in England do not receive all of their vital annual health checks including blood glucose, blood pressure and eye tests.